#United States #Baltimore #CRC #Gary Kay #Lifesavers Conference

Gary Kay, Ph.D. to Address Roadway Safety at Lifesavers Conference

Cognitive Research Corporation (CRC) is excited to announce that its Chief Scientific Officer, Dr. Gary Kay, is set to speak at the 2026 Lifesavers Conference on Roadway Safety, occurring from April 19 to April 21, 2026, at the Baltimore Convention Center. This prominent event brings together leaders, industry professionals, and policy experts to share insights aimed at enhancing traffic safety and reducing injuries on our roads.

Focus on Driving Impairment

Dr. Kay will be part of a crucial panel discussing "Countermeasures, Regulations, Research to Prevent Driving Under the Influence of Prescription & Over-the-Counter Medications." This session, scheduled for April 20 from 9:30 AM to 10:45 AM EST, will feature a range of perspectives from federal regulators and leaders in research, focusing on the growing concern of medication-related driving impairment.

With an increasing array of prescription and over-the-counter medications available, understanding their potential effects on driving performance is of utmost importance. This topic has become a regulatory priority, especially as new therapeutic categories, including psychedelics, emerge in clinical settings.

Addressing Critical Issues

Panel discussions will delve into various aspects of driving impairment, including:

• - The impact of medications on cognitive and psychomotor skills
• - Regulatory expectations and scientific approaches to assessing drug effects
• - Strategies for risk reduction associated with medication use while driving

Dr. Kay’s expertise in neuropsychology and clinical trials positions him uniquely to contribute valuable insights into these discussions. His work with the U.S. Food and Drug Administration (FDA) and the National Highway Traffic Safety Administration (NHTSA) gives him an informed perspective essential for navigating the complexities of drug-impaired driving.

"Understanding how medications impact real-world functioning, including driving, requires both scientific rigor and practical application," Dr. Kay stated. This discussion is vital as stakeholders strive for patient safety while adhering to scientific standards that promote therapeutic development.

CRC's Role in CNS Clinical Trials

Cognitive Research Corporation has a long-standing commitment to research in central nervous system (CNS) clinical trials. These trials often assess the cognitive and functional outcomes related to medication usage. A focal point of their methodology includes dedicated driving studies that utilize simulation technologies to evaluate the effects of both investigational and approved therapies on driving ability, thereby providing critical data needed by regulatory authorities.

CRC has conducted over 20 studies in this area, demonstrating a significant impact on FDA decision-making processes and labeling outcomes. Their experience extends to supporting complex neuropsychiatric programs, having conducted 10 clinical trials involving psychedelics.

About the Lifesavers Conference

The Lifesavers Conference is among the largest annual gatherings dedicated to roadway safety and injury prevention in the United States, drawing thousands from various sectors such as law enforcement, government agencies, academia, and industry. The conference allows participants to share research findings, policy updates, and operational practices aimed at reducing roadway fatalities. Attendees can look forward to engaging discussions and action-oriented sessions designed to drive change.

The 2026 event is set to provide a platform for the continued advancement of roadway safety practices. For those interested in learning more about the Lifesavers Conference, information is available at Lifesavers Conference Website.

About Cognitive Research Corporation

Cognitive Research Corporation is a leading neuroscience-focused contract research organization dedicated to advancing clinical trials across various domains, including neurology and psychiatry. With two decades of expertise solely focused on CNS research, CRC excels in providing actionable, regulator-ready results. Their dedicated teams and collaborative relationships ensure the delivery of high-quality data and dependable execution throughout clinical trials.

For further details, CRC can be reached through their website at Cognitive Research Corporation.